Gema Biotech S.A.
🇦🇷Argentina
- Country
- 🇦🇷Argentina
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 251
- Market Cap
- -
- Website
- https://www.gemabiotech.com
Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2018-01-19
- Lead Sponsor
- Gema Biotech S.A.
- Target Recruit Count
- 120
- Registration Number
- NCT03404752
- Locations
- 🇦🇷
COIBA, Buenos Aires, Bs As, Argentina
Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 )
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Gema Biotech S.A.
- Target Recruit Count
- 141
- Registration Number
- NCT03403140
- Locations
- 🇦🇷
Instituto Medico CER, Bs As, Argentina
Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Gema Biotech S.A.
- Target Recruit Count
- 168
- Registration Number
- NCT03332719
- Locations
- 🇦🇷
Instituto Medico CER, Bs As, Argentina
A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART
- First Posted Date
- 2015-05-27
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- Gema Biotech S.A.
- Target Recruit Count
- 106
- Registration Number
- NCT02454556
- Locations
- 🇦🇷
Halitus Instituto Médico, Buenos Aires, Caba, Argentina
© Copyright 2024. All Rights Reserved by MedPath